This document describes a novel family of medicinal nanoparticles called porphyrine adducts of fullerene C60. These nanoparticles are designed to selectively deliver the paramagnetic isotope 25Mg2+ to cell compartments in heart muscle and lymphocytes. This targeted delivery of 25Mg2+ promotes a local increase in ATP production through a magnetic isotope effect, even under low oxygen conditions. The nanoparticles are capable of smart behavior by gradually releasing 25Mg2+ only in response to metabolic acidosis caused by tissue hypoxia. The nanoparticles have low toxicity, are safe and efficient, and can be eliminated from the body through normal metabolic pathways. They show potential for both short and long term medical applications.